CSS
TNGX icon

Cubist Systematic Strategies’s Tango Therapeutics TNGX Stock Holding History

Cubist Systematic Strategies’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.02M Buy
+240,655
New +$1.63M 0.01% 1566
2024
Q1 		– Sell
-101,332
Closed -$1M – 4275
2023
Q4 		$1M Buy
+101,332
New +$880K 0.01% 2058
2023
Q2 		– Sell
-16,794
Closed -$66.3K – 4300
2023
Q1 		$66.3K Buy
+16,794
New +$97.5K ﹤0.01% 3523
2022
Q4 		– Sell
-10,594
Closed -$38K – 4596
2022
Q3 		$38K Sell
10,594
-60,295
-85% -$257K ﹤0.01% 4162
2022
Q2 		$321K Buy
70,889
+13,009
+22% +$78.8K ﹤0.01% 3386
2022
Q1 		$439K Buy
+57,880
New +$502K ﹤0.01% 2617
2021
Q4 		– Sell
-15,792
Closed -$204K – 3631
2021
Q3 		$204K Buy
+15,792
New +$189K ﹤0.01% 2581

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cubist Systematic Strategies's TNGX Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Tango Therapeutics (TNGX) in Q3 2025: 240,655 shares worth $2.02M. The stake represents 0.01% of the portfolio and ranks #1566 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in TNGX as recently as Q4 2023.

Cubist Systematic Strategies first reported a position in TNGX in Q3 2021 and has held it in 7 quarters since. 141 funds tracked by Wall St. Rank hold TNGX as of Q3 2025.

  • Cubist Systematic Strategies held 240,655 shares of Tango Therapeutics worth $2.02M as of Q3 2025.
  • Tango Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • Tango Therapeutics made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1566 holding.
  • Cubist Systematic Strategies first reported a position in Tango Therapeutics in Q3 2021 and has held it in 7 quarters since.
  • 141 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.